SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-20-172628
Filing Date
2020-06-18
Accepted
2020-06-18 17:13:57
Documents
5
Period of Report
2020-08-20

Document Format Files

Seq Description Document Type Size
1 PRE 14A d932120dpre14a.htm PRE 14A 383310
2 GRAPHIC g932120g0617065249014.jpg GRAPHIC 6390
3 GRAPHIC g932120g0617065249216.jpg GRAPHIC 1423
4 GRAPHIC g932120g0617065249372.jpg GRAPHIC 7178
5 GRAPHIC g932120g0617065249544.jpg GRAPHIC 3780
  Complete submission text file 0001193125-20-172628.txt   411091
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33057 | Film No.: 20973500
SIC: 2834 Pharmaceutical Preparations